{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:57:45Z","timestamp":1648753065405},"reference-count":40,"publisher":"Japan Society for Clinical Immunology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2177\/jsci.40.179","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T22:14:30Z","timestamp":1501020870000},"page":"179-189","source":"Crossref","is-referenced-by-count":1,"title":["Omenn Syndrome and DNA recombination defects"],"prefix":"10.2177","volume":"40","author":[{"given":"Akihiro","family":"YACHIE","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Woodbine, L., et al.: The clinical impact of deficiency in DNA non-homologous end-joining. DNA Repair<\/i>. 16<\/b>: 84-96, 2014."},{"key":"2","unstructured":"2) Lees-Miller. S.P., Meek, K.: Repair of DNA double strand breaks by non-homologous endo joining. Biochimie<\/i>. 85<\/b>: 1161-1173, 2003."},{"key":"3","unstructured":"3) de Villartay, J.-P.: Congenital defects in V(D)J recombination. Brit Med Bulletin<\/i>. 114<\/b>: 157-167, 2015."},{"key":"4","unstructured":"4) Meek, K., et al.: The DNA-dependent protein kinase: the director at the end. Immunol Rev<\/i>. 200<\/b>: 132-141, 2004."},{"key":"5","unstructured":"5) Villa, A., et al.: Partial V(D)J recombination activity leads to Omenn syndrome. Cell<\/i>. 93<\/b>: 885-896, 1998."},{"key":"6","unstructured":"6) Villa, A., et al.: V(D)J recombination defects in lymphocytes due to RAG<\/i> mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood<\/i>. 97<\/b>: 81-88, 2001."},{"key":"7","unstructured":"7) Wada, T., et al.: Characterization of immune function and analysis of RAG<\/i> gene mutations in Omenn syndrome and related disorders. Clin Exp Immunol<\/i>. 119<\/b>: 148-155, 2000."},{"key":"8","unstructured":"8) Okamoto, H., et al.: Clonotypic analysis of T cell reconstitution after haematopoietic stem cell transplantation (HSCT) in patients with severe combined immunodeficiency. Clin Exp Immunol<\/i>. 148<\/b>: 450-460, 2007."},{"key":"9","unstructured":"9) Omenn, G.S.: Familial reticuloendotheliosis with eosinophilia. N Engl J Med<\/i>. 273<\/b>: 427-432, 1965."},{"key":"10","unstructured":"10) Chen, K., et al.: Autoimmunity due to RAG deficiency and estimated disease incidence In RAG1\/RAG2<\/i> mutations. J Allergy Clin Immunol<\/i>. 133<\/b>: 880-882, 2015."},{"key":"11","unstructured":"11) Borte, S., et al.: Neonatal screening for severe combined immunodeficiency diseases using high-throughput real-time PCR. Blood<\/i>. 119<\/b>: 2552-2555, 2012."},{"key":"12","unstructured":"12) Kamae, C., et al.: Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin -deleting recombination excision circles. J Allergy Clin Immunol<\/i>. 131<\/b>: 1437-1440, 2013."},{"key":"13","unstructured":"13) Schandene, L., et al.: T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol<\/i>. 23<\/b>: 56-60, 1993."},{"key":"14","unstructured":"14) Ehl, S., et al.: A variant of SCID with specific immune responses and predominance of T cells. J Clin Invest<\/i>. 115<\/b>: 3140-3148, 2005."},{"key":"15","unstructured":"15) John, T., et al.: Unrelated hematopoietic stem cell transplantation in a patient with combined immunodeficiency with granulomatous disease and autoimmunity secondary to RAG deficiency. J Clin Immunol<\/i>. 36<\/b>: 725-732, 2016."},{"key":"16","unstructured":"16) Abraham, R.S., et al.: Adult-onset manifestation of idiopathic T-cell lymphopenia due to a heterozygous RAG1<\/i> mutation. J Allergy Clin Immunol<\/i>. 131<\/b>: 1421-1423, 2013."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) de Villartay, J-P.: Congenital defects in V(D)J recombination. Brit Med Bulletin<\/i>. 114<\/b>: 157-167, 2015.","DOI":"10.1093\/bmb\/ldv020"},{"key":"18","unstructured":"18) Lee, Y.N., et al.: A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination- activating gene 1 deficiency. J Allergy Clin Immunol<\/i>. 133<\/b>: 1099-1108, 2014."},{"key":"19","unstructured":"19) IJspeert, H., et al.: Similar recombination-activating gene (RAG<\/i>) mutations result in similar immunobiological effects but in different clinical phenotypes. J Allergy Clin Immunol<\/i>. 133<\/b>: 1124-1133, 2014."},{"key":"20","unstructured":"20) Notarangelo, L.D., et al.: Human RAG mutations: biochemistry and clinical implications. Nat Rev Immunol<\/i>. 16<\/b>: 234-246, 2016."},{"key":"21","unstructured":"21) Moshous, D., et al.: A new gene involved in DNA double-strand break repair and V(D)J recombination is located on chromosome 10p. Hum Mol Genet<\/i>. 9<\/b>: 583-588, 2000."},{"key":"22","unstructured":"22) Moshous, D., et al.: Artemis, a novel DNA double-strand break repair\/V(D)J recombination protein, is mutated in human severe combined immunodeficiency. Cell<\/i>. 105<\/b>: 177-186, 2001."},{"key":"23","unstructured":"23) Brndt, V.L., Roth, D.B.: Artemis: guarding small children and, now, the genome. J Clin Invest<\/i>. 111<\/b>: 315-316, 2003."},{"key":"24","unstructured":"24) Moshous, D., et al.: Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis<\/i>. J Clin Invest<\/i>. 111<\/b>: 381-387, 2003."},{"key":"25","unstructured":"25) Felgentreff, K., et al.: Functional analysis of naturally occurring DCLRE1C<\/i> mutations and correlation with the clinical phenotype of ARTEMIS deficiency. J Allergy Clin Immunol<\/i>. 136<\/b>: 140-150, 2015."},{"key":"26","unstructured":"26) Lee, P.P., et al.: The many faces of Artemis-deficient combined immunodeficiency \u2013 two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation. Clin Immunol<\/i>. 149<\/b>: 464-474, 2013."},{"key":"27","unstructured":"27) O'Marcaigh, A.S., et al.: Bone marrow transplantation for T\u2212<\/sup> B\u2212<\/sup> severe combined immunodeficiency disease in Athabascan-speaking native Americans. Bone Marrow Transplant<\/i>. 27<\/b>: 703-709, 2001."},{"key":"28","unstructured":"28) van der Burg, M., et al.: A DNA-PKcs mutation in a radiosensitive T-B-SCID patient inhibits Artemis activation and nonhomologous end-joining. J Clin Invest<\/i>. 119<\/b>: 91-98, 2009."},{"key":"29","unstructured":"29) Woodbine, L., et al.: PRKDC mutations in a SCID patient with profound neurological abnormalities. J Clin Invest<\/i>. 123<\/b>: 2969-2980, 2013."},{"key":"30","unstructured":"30) Mathieu, A-L., et al.: PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity. J Allergy Clin Immunol<\/i>. 135<\/b>: 1578-1588, 2015."},{"key":"31","unstructured":"31) Buck, D., et al.: Cernunnos, a novel nonhomologous endo-joining factor, is mutated in human immunodeficiency with microcephaly. Cell<\/i>. 124<\/b>: 287-299, 2006."},{"key":"32","unstructured":"32) Yano, K., et al.: Cernunnos\/XLF: A new player in DNA double-strand break repair. Int J Biochem Cell Biol<\/i>. 41<\/b>: 1237-1240, 2009."},{"key":"33","unstructured":"33) Mahaney, B.L., et al.: XRCC4 and XLF from long helical protein filaments suitable for DNA end protection and alignment to facilitate DNA double strand break repair. Biochem Cell Biol<\/i>. 91<\/b>: 31-41, 2013."},{"key":"34","unstructured":"34) Cipe, F.E., et al.: Cernunnos\/XLF deficiency: A syndromic primary immunodeficiency. Case Reports in Pediatrics<\/i>. 2014<\/b>: 1-4, 2014."},{"key":"35","unstructured":"35) O'Driscoll, M., et al.: DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell<\/i>. 8<\/b>: 1175-1185, 2001."},{"key":"36","unstructured":"36) Chistiakov, D.A., et al.: Ligase IV syndrome. Eur J Med Genet<\/i>. 52<\/b>: 373-378, 2009."},{"key":"37","unstructured":"37) Gatz, S.A., et al.: Development\/plasticity\/repair requirement for DNA ligase IV during embryonic neuronal development. J Neurosci<\/i>. 31<\/b>: 10088-100100, 2011."},{"key":"38","unstructured":"38) Murray, J.E., et al.: Extreme growth failure is a common presentation of ligase IV deficiency. Hum Mutation<\/i>. 35<\/b>: 76-85, 2013."},{"key":"39","unstructured":"39) Wada, T., et al.: Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood<\/i>. 106<\/b>: 2099-2101, 2005."},{"key":"40","unstructured":"40) Wada, T., et al.: Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome. Blood<\/i>. 112<\/b>: 1872-1875, 2008."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["Omenn\u75c7\u5019\u7fa4\u3068DNA\u518d\u69cb\u6210\u969c\u5bb3"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/40\/3\/40_179\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T16:11:48Z","timestamp":1569946308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/40\/3\/40_179\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.40.179","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}